A genetic blueprint for cardiac development

Nature

Volumn 407, Issue 6801, 2000, Pages 221-226

  Srivastava, Deepak ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; GENE MUTATION; HEART DEVELOPMENT; HUMAN; MEDICAL GENETICS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL LINEAGE; CORONARY CIRCULATION; HEART; HEART DEFECTS, CONGENITAL; HEART VALVES; MORPHOGENESIS; MYOCARDIUM;

EID: 0034648772     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35025190     Document Type: Review

References (54)

1. Schultheis, T. M., Xydas, S. & Lassar A. B. Induction of avian cardiac myogenesis by anterior endoderm. Development 121, 4203-4214 (1995).
2. Harvey, R. P. NK-2 homeobox genes and heart development. Dev. Biol. 178, 203-216 (1996).
3. Gajewski, K., Kim, Y., Lee, Y. M., Olson, F. N. & Schulz, R. A. D-Mef2: a target for tinman activation during Drosophila heart development. EMBO J. 16, 515-522 (1998).
4. Durocher, D., Charron, F., Warren, R., Schwartz, R. J. & Nemer, M. The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J. 16, 5687-5696 (1997).
5. Schwartz, R. J. & Olson, E. N. Building the heart piece by piece: modularity of cis elements regulating Nkx2.5 transcription. Development 126, 4187-4192 (1999).
6. Fu, Y., Yan, W., Mohun, T. J. & Evans, S. M. Vertebrate tinman homologues XNkx2-3 and XNkx2-5 are required for heart formation in a functionally redundant manner. Development 125, 4439-4449 (1998).
7. Grow, M. W. & Kreig, P. A. Tinman function is essential for vertebrate heart development: elimination of cardiac differentiation by dominant inhibitory mutants of the tinman-related genes, XNkx2-3 and XNkx2-5. Dev. Biol. 204, 187-196 (1998).
8. Molkentin, J., Lin, Q., Duncan, S. A. & Olson, E. N. Requirement of the GATA4 transcription factor for heart tube formation and ventral morphogenesis. Genes Dev. 11, 1061-1072 (1997).
9. Kuo, C. T. et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 11, 1048-1060 (1997).
10. Reiter, J. F. et al. Gata5 is required for the development of the heart and endoderm in zebrafish. Genes Dev. 13, 2983-2995 (1999).
11. Capdevila, J., Vogan, K. J., Tabin, C. J. & Belmonte, J. C. Mechanism of left-right determination in vertebrates. Cell 101, 9-21 (2000).
12. Hyer, J. et al. Induction of Purkinje fiber differentiation by coronary arterialization. Proc. Natl Acad. Sci. USA 96, 13214-13218 (1999).
13. Srivastava, D., Cserjesi, P. & Olson, E. N. New subclass of bHLH proteins required for cardiac morphogenesis. Science 270, 1995-1999 (1995).
14. Srivastava, D. et al. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nature Genet. 16, 154-160 (1997).
15. Firulli, A. B., McFadden, D. G., Lin, Q., Srivastava, D. & Olson, E. N. Heart and extra embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nature Genet. 8, 266-270 (1998).
16. Riley, P., Anson-Cartwright, I., & Cross, J. C. The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nature Genet. 18, 271-275 (1998).
17. Biben, C. & Harvey, R. P. Homeodomain factor Nkx2-5 controls left/right asymmetric expression of bHLH gene eHAND during murine heart development. Genes Dev. 11, 1357-1369 (1997).
18. Bao, Z., Bruneau, B. G., Seidman, J. G., Seidman, C. E. & Cepko, C. L. Regulation of chamber-specific gene expression in the developing heart by Irx4. Science 283, 1161-1164 (1999).
19. Bruneau, B. G., et al. Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Dev. Biol. 217, 266-277 (2000).
20. Yelon, D. et al. Parallel roles for the bHLH transcription factor HAND2 in zebrafish and pectoral fin development. Development 127, 2573-2582 (2000).
21. Lin, Q., Schwarz, J., Bucana, C. & Olson, E. N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 276, 1404-1407 (1997).
22. Pereira, F. A., Qui, Y., Zhou, G., Tsai, M. & Tsai, S. The orphan nuclear receptor COUP-TFH is required for angiogenesis and heart development. Genes Dev. 13, 1037-1049 (1999).
23. Dyson, E. et al. Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha-/-mice. Proc. Natl Acad. Sci. USA 92, 7386-7390 (1995).
24. Lee, K. F. et al. Requirement for neuregulin receptor erbB2 in neutral and cardiac development. Nature 378, 394-398 (1995).
25. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
26. Suri, C. et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180 (1996).
27. Brown, C. B., Boyer, A. S., Runyan, R. B. & Barnett, J. V. Requirement of type III TGF beta receptor for endocardial cell transformation in the heart. Science 283, 2080-2082 (1999).
28. Ranger, A. M. et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392, 186-190 (1998).
29. De la Pompa, J. L. et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392, 182-186 (1998).
30. Galvin, K. M. et al. A role for smad6 in development and homeostasis of the cardiovascular system. Nature Genet. 24, 171-174 (2000).
31. Kirby, M. L. & Waldo, K. L. Neural crest and cardiovascular patterning. Circ. Res. 77, 211-215 (1995).
32. Kurihara, Y. et al. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J. Clin Invest.96, 293-300 (1995).
33. Clouthier, D. E. et al. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125, 813-824 (1998).
34. Thomas, T. et al. A signaling cascade involving endothelin-1, dHAND and Msx1 regulates development of neural crest-derived branchial arch mesenchyme. Development 125, 3005-3014 (1998).
35. Yamagishi, H., Olson, E. N. & Srivastava, D. The bHLH transcription factor, dHAND, is required for vascular development. J. Clin. Invest. 105, 261-270 (2000).
36. Kawasaki, T. et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 126, 4854-4902 (1999).
37. Iida, K. et al. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124, 4627-1638 (1997).
38. Li, J., Liu, K. C., Jin, F., Lu, M. M. & Epstein, J. A. Transgenic rescue of congenital heart disease and spina bifida in Splotch mice. Development 126, 2495-2503 (1999).
39. Gruber, P. J. et al. RXR alpha deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion, and ventricular muscle defects in mice. J. Clin. Inv. 98, 1332-1343 (1946).
40. Zhong, T. P., Rosenberg, M., Mohideen, M. A., Weinstein, B. & Fishman, M. C. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287, 1820-1824 (2000).
41. Satoda, M. et al. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nature Genet. 25, 42-46 (2000).
42. Emanuel, B. S., Budarf, M. L., & Scambler, P. J. in Heart Development (eds Harvey, R. P. & Rosenthal, N.) 463-478 (Academic, New York, 1998).
43. Lindsay, E. A. et al. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401, 379-383 (1999).
44. Yamagishi, H., Garg, V., Matsuoka, R., Thomas, T. & Srivastava, D. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science 283, 1158-1161 (1999).
45. Schott, J.-J. et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281, 108-111 (1998).
46. Benson, D. W. et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 104, 1567-1573 (1999).
47. Basson, C. T. et al. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nature Genet. 15, 30-35 (1997).
48. Li, Q. Y. et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brathyury (T) gene family. Nature Genet. 15, 21-29 (1997).
49. Basson, C. T. et al. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc. Natl Acad. Sci. USA 96, 2919-2924 (1999).
50. Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notchl. Nature Genet. 16, 243-251 (1997).
51. Oda, T., Elkahloun, A. G. & Pike, B. L. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nature Genet. 16, 235-242 (1997).
52. Krantz, I. D. et al. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am. J. Hum. Genet. 84, 56-60 (1999).
53. Curran, M. E. et al. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 73, 159-168 (1993).
54. Dietz, H. C. et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352, 279-281 (1991).